48m
Hosted on MSNHims & Hers Super Bowl controversy: What the ad left out about its 'alternative' weight-loss drugsThe telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide ...
While this condition can be caused by diabetes, tissue disease and neurological disorders, which damage the nerves and blood ...
Rapid weight loss affects muscle mass and can increase the risk of osteoporosis. But now there is good news for people taking weight loss medication who may be at risk. A new study indicates that the ...
Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.
A well-known class of drugs used to manage type 2 diabetes and control weight could offer hope for patients who also struggle ...
Furhman highlighted that year-to-date (YTD) web traffic for Hims Hers Health has jumped by 51% compared to the same period last year. This surge in online interest is consistent with industry patterns ...
Experts from five states have sounded the alarm about blockbuster weight loss drugs like Ozempic leaving users blind, ...
As Ozempic use rises, some patients report unexpected nasal symptoms, prompting researchers to investigate this new and unusual side effect.
The spot “is a clear violation” of the FDCA, “which requires that advertising for prescription drugs — including compounded ...
Medical experts have raised concerns over popular weight loss drugs like Ozempic and Mounjaro after emerging evidence found ...
Controversy surrounded Him & Hers’ commercial, called ‘Sick of the System’, in the lead up to America’s biggest sporting ...
Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results